News from merck A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

27 May, 2020, 14:15 BST Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

Merck, a leading science and technology company, and Baylor College of Medicine, Houston, Texas, USA, today announced an extension of their ongoing...


11 May, 2020, 14:00 BST Merck Granted U.S. Patents for Foundational CRISPR-Cas9 Technology

Merck, a leading science and technology company, today announced that two of its CRISPR-Cas9-assisted genome-editing patents have been allowed in the ...


21 Apr, 2020, 13:00 BST Merck Boosts Commercial Viral Vector and Gene Therapy Manufacturing Capacity

Merck, a leading science and technology company, today announced a second Carlsbad, California, U.S.A.-based facility for its BioReliance® viral and...


14 Apr, 2020, 13:00 BST Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

Merck, a leading science and technology company, and The Jenner Institute today announced that the Jenner Institute has laid the foundation for...


07 Apr, 2020, 13:00 BST Merck Awarded Second U.S. Patent for CRISPR Gene-Editing Technology

Merck, a leading science and technology company, today announced that the United States Patent and Trademark Office has granted the company's patent...


03 Mar, 2020, 19:00 GMT Merck's New LANEXO™ System to Improve Scientists' Productivity in the Lab

Merck, a leading science and technology company, today launched its LANEXO™ Lab Inventory, Safety and Compliance Management System, a new digital...


19 Dec, 2019, 13:00 GMT Merck Licenses Foundational CRISPR Integration Technology to Promega

Merck, a leading science and technology company, today announced that it has signed a license agreement providing Promega Corp., a global life...


26 Nov, 2019, 13:00 GMT Japan and Singapore Grant CRISPR Patents to Merck

Merck, a leading science and technology company, today announced that the Japan Patent Office and the Intellectual Property Office of Singapore have...


12 Nov, 2019, 13:00 GMT Merck Licenses CRISPR Gene-Editing Technology to Evotec

Merck, a leading science and technology company, today announced that it has signed a license agreement providing Evotec SE access to Merck's...


19 Aug, 2019, 13:00 BST Merck Granted Seven Additional CRISPR Patents, Bringing Total to 20 Worldwide

Merck, a leading science and technology company, today announced that the European, Israeli, South Korean and U.K. intellectual property offices have ...


18 Jul, 2019, 13:00 BST Merck and Broad Institute Announce CRISPR License Framework to Encourage Innovation

Merck, a leading science and technology company, and the Broad Institute of MIT and Harvard (Boston, Massachusetts) today announced an agreement to...


16 Jul, 2019, 08:00 BST Merck's Embracing Carers™ Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers

Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched 'Time Counts,' a social media-led ...


20 Jun, 2019, 19:33 BST Merck's Massachusetts-based Business Sectors Named 'Best Places to Work' by Boston Business Journal

Merck, a leading science and technology company, today announced that its Massachusetts-based business sectors have been named to the Boston Business ...


22 May, 2019, 13:00 BST Experts Discuss Decentralized Manufacturing to Tackle Neglected Tropical Diseases and Promote Universal Health Coverage at World Health Assembly Event

Merck, a leading science and technology company, today hosted a panel discussion on the occasion of the 72nd World Health Assembly in Geneva,...


20 May, 2019, 13:00 BST Merck Joins TRANSVAC2 Program to Advance Vaccine Development and Manufacturing

Merck, a leading science and technology company, today announced its participation in a collaboration with the Vaccine Formulation Institute and the...


10 May, 2019, 18:45 BST Positive Phase II Data Further Highlights Clinical Proof of Concept for Evobrutinib, First Oral Bruton´s Tyrosine Kinase (BTK) Inhibitor to Report Positive Phase II Clinical Results in MS

Merck, a leading science and technology company, today announced new 48-week results of the double-blind, randomised, placebo-controlled, Phase II...


28 Mar, 2019, 08:13 GMT Merck Invests in Expansion of Manufacturing Capacity for Biotech Medicines

Merck, a leading science and technology company, today announced an investment of €150 million (165 million Swiss francs) in its manufacturing site...


20 Mar, 2019, 09:30 GMT Merck Opens First M Lab™ Collaboration Center in Europe

Merck, a leading science and technology company, today officially opened its new M Lab™ Collaboration Center in Molsheim, France. The center is...


19 Mar, 2019, 10:30 GMT Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China

Merck, a leading science and technology company, today announced the signing of a non-binding Memorandum of Understanding with Chinese biotech...


04 Mar, 2019, 13:00 GMT Merck Awarded Canadian CRISPR Nickase Patent for Foundational Genome-Editing Technology

Merck, a leading science and technology company and leader in genome editing, today announced that the Canadian Patent Office has allowed Merck's...


19 Feb, 2019, 13:00 GMT Merck Receives First U.S. Patent for Improved CRISPR Genome-Editing Method

Merck, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has...


10 Dec, 2018, 16:30 GMT Merck and genOway Form CRISPR/Cas9 Strategic Alliance to Develop Rodent Models

Merck, a leading science and technology company and leader in genome editing, today announced a strategic alliance in the CRISPR/Cas9 rodent model...


27 Nov, 2018, 13:00 GMT Merck Wins Two R&D 100 Awards for Innovation in 2018

Merck, a leading science and technology company, today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring ...


23 Nov, 2018, 09:00 GMT New campaign supporting UK carers to recognise their role launched

Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched a new campaign to help...